NDC 80425-0316-01 - Doxepin Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0316
- Requested NDC
- 80425-0316-01
- Package NDCs from labels
- 80425-0316-1, 80425-0316-2, 80425-0316-3, 80425-0316-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Doxepin Hydrochloride - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0316-1 | Doxepin Hydrochloride | 30 in 1 BOTTLE | CAPSULE | 30 | 2 | |
| 80425-0316-2 | Doxepin Hydrochloride | 60 in 1 BOTTLE | CAPSULE | 60 | 2 | |
| 80425-0316-3 | Doxepin Hydrochloride | 90 in 1 BOTTLE | CAPSULE | 90 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0316 | DOXEPIN HYDROCHLORIDE CAPSULE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 2 | Current NDC, 3 package rows | 20250102_f900bac4-02f2-6bf3-e053-6394a90a2161.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0316-1 | EA - Each | 80425-0316 | 28464baa-062f-4d04-b030-cd4f5b80a754 | 1 | 2023-06-06 |
| 80425-0316-2 | EA - Each | 80425-0316 | 7bca9d58-efc4-4209-8a21-2693fc3e32f3 | 1 | 2023-06-06 |
| 80425-0316-3 | EA - Each | 80425-0316 | f2b33fc2-fff3-4425-b00a-1fb444945861 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxepin hydrochloride | DOXEPIN HYDROCHLORIDE | Bryant Ranch Prepack | 2cacce3a-4986-44a8-b4aa-6edb076d87bf | 2023-11-16 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| Doxepin hydrochloride | DOXEPIN HYDROCHLORIDE | Bryant Ranch Prepack | 0cbf87df-c447-4225-81f5-92c4bc3ef81d | 2023-10-23 | Boxed warning, Warnings, Adverse reactions | 3U9A0FE9N5 |
| Doxepin hydrochloride | DOXEPIN HYDROCHLORIDE | Proficient Rx LP | 7cfbb3d0-f19f-4977-ad0f-77676a8c6f83 | 2023-09-01 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Amneal Pharmaceuticals NY LLC | dd8d5edd-7b08-4061-86e6-c4179da89c0d | 2023-08-17 | Warnings, Adverse reactions | 3U9A0FE9N5 |
| DOXEPIN | DOXEPIN | Aurobindo Pharma Limited | 29b3bf98-2c57-4d87-b5eb-5232e46dc639 | 2023-07-13 | Warnings, Adverse reactions | 3U9A0FE9N5 |
| Doxepin hydrochloride | DOXEPIN HYDROCHLORIDE | Bryant Ranch Prepack | 41046d94-1443-4bbd-96d0-8463604ae459 | 2023-06-30 | Boxed warning, Warnings, Adverse reactions | 3U9A0FE9N5 |
| Doxepin | DOXEPIN | Actavis Pharma, Inc. | c42333f8-1add-4f33-9458-6fe4436874a1 | 2023-06-01 | Warnings, Adverse reactions | 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | 14002bad-2577-436d-91ca-ec1b80ab0c97 | 2023-03-17 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 842b595b-dc54-4898-a178-1d2241cc065f | 2023-01-27 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| Doxepin hydrochloride | DOXEPIN HYDROCHLORIDE | Proficient Rx LP | acb696a8-a74c-4c5d-9ce3-88f67558c2f2 | 2022-09-01 | Boxed warning, Warnings, Adverse reactions | 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Proficient Rx LP | 6ce7fde2-2d47-4238-9beb-555d352f4657 | 2022-05-02 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| doxepin hydrochloride | DOXEPIN HYDROCHLORIDE | Currax Pharmaceuticals LLC dba Cypress, Hawthorn, Macoven | 5b4dba99-6b66-4091-94f1-bf5f021c688a | 2022-01-20 | Warnings, Adverse reactions | 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Florida Pharmaceutical Products, LLC | b787a283-f882-e1f0-e053-2a95a90a8975 | 2021-09-24 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| doxepin hydrochloride | DOXEPIN HYDROCHLORIDE | Teva Pharmaceuticals USA, Inc. | 4a4eab1c-8e19-48f5-9216-09ab83eaa5f8 | 2021-06-01 | Warnings, Adverse reactions | 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Appco Pharma LLC | abf4c515-8888-4733-80a0-fd4e1cdb84a2 | 2021-04-29 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Proficient Rx LP | e98f371e-f7fe-4c8f-9491-6eb4c53d43ad | 2021-02-01 | Boxed warning, Warnings, Adverse reactions | 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Contract Pharmacal Corp. | abbf7078-a012-4e1a-e053-2995a90a792d | 2020-08-06 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 10d9eba6-30d1-448a-8d92-a1a02df03303 | 2017-09-05 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| PRUDOXIN | DOXEPIN HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | ca53346b-8ab3-4722-98f6-cf272706d3fa | 2017-06-29 | Warnings, Adverse reactions | 3U9A0FE9N5 |
| Zonalon | DOXEPIN HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | 5f302247-525e-4acc-852b-00eb1d79af4b | 2017-06-14 | Warnings, Adverse reactions | 3U9A0FE9N5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.